알부민 시장 : 제품 유형별, 용도별, 형태별, 최종사용자별, 지역별

Albumin Market is estimated to be valued at USD 7.80 Bn in 2026 and is expected to reach USD 13.11 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

The global albumin market represents a critical segment within the biopharmaceutical industry, encompassing human serum albumin (HSA) and recombinant albumin products that serve essential therapeutic and diagnostic applications. Albumin, the most abundant protein in human plasma, constitutes approximately 50-60% of total plasma proteins and plays vital roles in maintaining oncotic pressure, transporting various substances including hormones, fatty acids, and drugs, and serving as a biomarker for nutritional and liver function assessment.

The market primarily caters to clinical applications including volume replacement therapy, treatment of hypoalbuminemia, burn and trauma care, liver disease management, and nephrotic syndrome treatment. Additionally, albumin finds extensive use in cell culture media, vaccine production, drug formulation, and various research applications. The market is characterized by stringent regulatory frameworks due to the blood-derived nature of most albumin products, driving continuous innovation in plasma fractionation technologies and recombinant production methods. Geographic variations in plasma availability, regulatory approval processes, and healthcare infrastructure significantly influence market dynamics, while growing awareness of albumin's therapeutic benefits and expanding applications in regenerative medicine and drug delivery systems continue to shape market evolution across developed and emerging economies worldwide.

Market Dynamics

The global albumin market is propelled by several key drivers, including the rising prevalence of chronic diseases such as liver cirrhosis, nephrotic syndrome, and cardiovascular disorders that necessitate albumin replacement therapy, coupled with increasing surgical procedures and trauma cases requiring volume expansion solutions. The growing geriatric population worldwide, which is more susceptible to hypoalbuminemia and related complications, significantly contributes to market demand. Additionally, expanding applications in cell culture media for biopharmaceutical manufacturing, vaccine production, and research activities drive market growth, while technological advancements in plasma fractionation and purification processes enhance product quality and yield.

However, the market faces considerable restraints, primarily the limited availability of human plasma as a raw material, which creates supply-demand imbalances and price volatility. Stringent regulatory requirements for blood-derived products, including extensive safety testing and quality control measures, increase production costs and time-to-market. Safety concerns related to potential pathogen transmission, despite rigorous screening protocols, continue to pose challenges for market acceptance. Furthermore, high production costs associated with plasma collection, processing, and purification technologies limit market accessibility, particularly in price-sensitive regions. Nevertheless, significant opportunities emerge from the development of recombinant albumin products that eliminate dependency on human plasma and associated safety concerns, while offering consistent quality and unlimited supply potential. The expanding biotechnology sector, particularly in emerging markets, presents lucrative growth prospects, as does the increasing adoption of albumin in novel drug delivery systems and regenerative medicine applications.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global albumin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include leading plasma fractionation companies, biopharmaceutical manufacturers, and albumin product developers
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global albumin market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Human Serum Albumin
• Bovine Serum Albumin
• Recombinant Albumin
• Application Insights (Revenue, USD Bn, 2021 - 2033)
• Therapeutics
  • Oncology
  • Liver Diseases
  • Hypovolemia and Shock
  • Burn Treatment
  • Others (Trauma and Surgery)
• Excipient and Formulation
  • Vaccine Manufacturing
  • Drug Delivery
• Diagnostics
  • Blood Protein Analysis
  • Serum Protein Electrophoresis
• Research
  • Cell Culture Media
  • Protein Stability Studies
• Form Insights (Revenue, USD Bn, 2021 - 2033)
• Liquid Albumin
• Lyophilized/Powdered Albumin
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Pharmaceutical and Biotechnology Industry
• Hospitals and Clinics
• Diagnostic Laboratories
• Research Institutes
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• CSL Behring
• Grifols, S.A.
• Octapharma AG
• Baxter International Inc.
• Albumedix Ltd.
• Biotest AG
• HiMedia Laboratories Pvt. Ltd.
• Medxbio Pte Ltd.
• China Biologic Products, Inc.
• Thermo Fisher Scientific
• Ventria Bioscience Inc.
• SeraCare Life Sciences
• Merck KGaA
• Takeda Pharmaceutical Company Limited
• Kamada Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Albumin Market, By Product Type
  • Global Albumin Market, By Application
  • Global Albumin Market, By Form
  • Global Albumin Market, By End User
  • Global Albumin Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Albumin Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Human Serum Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Bovine Serum Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Recombinant Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Albumin Market, By Application, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Oncology
    • Liver Diseases
    • Hypovolemia and Shock
    • Burn Treatment
    • Others (Trauma and Surgery)
• Excipient and Formulation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Vaccine Manufacturing
    • Drug Delivery
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Blood Protein Analysis
    • Serum Protein Electrophoresis
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cell Culture Media
    • Protein Stability Studies

6. Global Albumin Market, By Form, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Liquid Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Lyophilized/Powdered Albumin
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Albumin Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pharmaceutical and Biotechnology Industry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Albumin Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Form, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• CSL Behring
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Grifols, S.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Octapharma AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Baxter International Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Albumedix Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biotest AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• HiMedia Laboratories Pvt. Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medxbio Pte Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• China Biologic Products, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ventria Bioscience Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SeraCare Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Takeda Pharmaceutical Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Kamada Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us